Clinical trial
Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
NCT01653925 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
- Lead sponsor
- CHU de Quebec-Universite Laval
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 28, 2010
- Completion date
- December 31, 2026
- Enrollment
- 120 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
low grade prostate cancer, prostatic neoplasms